all age groups – Page 9 – Communicable Diseases Research

Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis

Oncology

Published on 2021-01-212022-10-31
Journal: Frontiers in Oncology [Category] COVID-19,

COVID-19 in the elderly people and advances in vaccination approaches

노인의 코로나19와 예방 접종 접근법의 발전

Review

Published on 2020-12-012022-09-11
Journal: Human vaccines & immunotherapeutics [Category] 비임상, 임상,

Ischemic Stroke Occurs Less Frequently in Patients With COVID-19: A Multicenter Cross-Sectional Study

Observational Study

Published on 2020-12-012022-10-05
Journal: Stroke [Category] 임상,

Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project)

코로나19 예방 백신: 개별 환자 데이터를 포함하는 네트워크 메타 분석을 통한 살아있는 체계적인 검토를 위한 프로토콜(The LIVING VACCINE Project)

Protocol

Published on 2020-11-202022-09-10
Journal: Systematic Reviews [Category] COVID-19, meta-analysis, SARS,

[키워드] active placebo acute respiratory syndrome acute respiratory syndrome coronavirus aggregate data meta-analyses all age groups all-cause mortality analyzed approach assessment assessments best cause CENTRAL certainty certainty of evidence Clinical research clinical trial registries clinical trial registry clinical trials confidence coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 database dendritic dendritic cell described development Diagnosis disease Effect events Evidence GRADE identify inactivated include individual patient data meta-analyses life Messenger RNA meta-analyses Mortality network Network meta-analysis non-serious adverse non-serious adverse events not limited observational studies observational study once a week outcome pandemic participant patient data Placebo prevalent Prevent Primary outcomes Protein Protein subunit protocol Quality of life randomized clinical trial randomized clinical trials Research respiratory risk of bia SARS-CoV-2 secondary Secondary outcomes Serious Adverse Events severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spread standard care supplementary material systematic review Trial trial sequential analyses Vaccine vaccine for COVID-19 Vaccines Viral Viral vector
[DOI] 10.1186/s13643-020-01516-1 PMC 바로가기 [Article Type] Protocol

Possible protective role of 17β-estradiol against COVID-19

Article

Published on 2020-11-082022-10-30
Journal: Journal of allergy and infectious diseases [Category] COVID-19,

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study

Research Article

Published on 2020-10-202022-10-29
Journal: PLoS Medicine [Category] COVID-19, MERS, SARS,

[키워드] 95% CI acting acute respiratory syndrome age age and sex agency all age groups Analysis association Asthma C-statistic Care Case-control case-control study categories Chronic kidney disease chronic liver disease Classifier Comorbidity condition conditions contribute Control coronavirus COVID-19 COVID-19 epidemic Critical care database death deficiency defined demographic data Demographic variables develop diabetes diagnose diagnoses diagnostic digestive system disease distribution drug Electronic health record Electronic health records examined fatal COVID-19 fatal disease frailty Health health condition high risk hospital Hospital admission hospitalisation identify immune include increase in increased risk individual information ischemic heart disease kidney Logistic regression Lower respiratory tract Male sex medical record medical treatment MOST National nervous system Neurological disease nucleic acid test Odds ratio Older age past medical history positive positive test result primary care provided public health Rapid rate ratio Registered reported researcher resident risk risk factor Risk factors risk stratification SARS-CoV-2 selected severe coronavirus disease severe COVID-19 severe disease Sex shielding shown stroke the epidemic type 2 diabetes with COVID-19
[DOI] 10.1371/journal.pmed.1003374 PMC 바로가기 [Article Type] Research Article

COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics

Review

Published on 2020-10-032022-10-28
Journal: Pharmaceutics [Category] COVID-19,

[키워드] addition affected all age groups antiviral therapy approach approved Asymptomatic authorisation boost Chloroquine coronavirus COVID-19 current delivery development DNA drug drug delivery Efficacy Emergency use Face mask FDA Hydroxychloroquine immune response immune system immunization inactivated infected individual Infection Medicine mRNA opportunity Particle pathophysiology plasma therapy PPE Precaution preventive measure reduce Remdesivir reported SARS-CoV-2 SARS-COV-2 infection social distancing Spread subunit target the disease Therapeutics therapy Treatment Vaccine Vaccine development Viral vector virus World Health Organization
[DOI] 10.3390/pharmaceutics12100945 PMC 바로가기 [Article Type] Review

Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)

COVID-19 치료를 위한 중재: 메타 분석 및 시험 순차 분석을 통한 살아있는 체계적인 검토(The LIVING Project)

Research Article

Published on 2020-09-172022-08-13
Journal: PLoS Medicine [Category] Biochemistry, COVID-19, SARS,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus Admission adverse event adverse events aggregate data meta-analyses all age group all age groups all-cause mortality assessment caused certainty certainty of evidence Clinical effect Clinical research Clinical significance clinical trials Cochrane guidelines Comparisons conducted convalescent plasma coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients database development Dexamethasone driven by Effect Evidence evidence of experimental intervention Families GRADE high risk Hydroxychloroquine individual patient data meta-analyses individuals Infection intensive care International Intervention Intervention effects item Juul lack life Lopinavir Lopinavir–ritonavir mechanical ventilation meta-analyses Meta-analysis Network meta-analysis no effect no effects no evidence of nonserious adverse event nonserious adverse events on mechanical ventilation outbreak outcome outcomes participant Participants Patient patient data paucity of data performed Placebo Primary outcomes Quality of life random errors random-effects meta-analyses randomized clinical trial randomized clinical trials rapidly spreading disease rate ratio reduce reduced reducing Remdesivir renal replacement therapy replacement therapy Reporting Research researcher respiratory Respiratory failure review risk risk of bia risk of death risk ratio Ritonavir SARS-CoV-2 searched secondary Secondary outcomes Serious Adverse Event Serious Adverse Events severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 single trial single trial randomizing Sophie Spread standard care statistically significant systematic review systematic reviews Treatment treatment for COVID-19 treatment intervention treatment of COVID-19 treatments for COVID-19 treatments of COVID-19 Trial Trial methodology trial randomizing trial sequential analyses trial sequential analysis website with COVID-19
[DOI] 10.1371/journal.pmed.1003293 PMC 바로가기 [Article Type] Research Article

Coronavirus Disease 2019 (COVID-19) Associated With Febrile Status Epilepticus in a Child

Neurology

Published on 2020-08-182022-10-31
Journal: Cureus [Category] COVID-19,

All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England

Rapid Communication

Published on 2020-07-162022-10-31
Journal: Eurosurveillance [Category] Coronavirus, SARS,

[키워드] age all age groups all-cause mortality COVID-19 COVID-19 pandemic England EuroMOMO Europe First wave highest London Mortality pandemic Region
[DOI] 10.2807/1560-7917.ES.2020.25.28.2001239 PMC 바로가기 [Article Type] Rapid Communication